Abstract
The vulva is a significant organ that was left unattended for a long time only to look at it carefully until it is diseased. Recent changes in women empowerment, instrumentation, and scientific advancement, drawn attention not only towards early diagnosis and treatment of female genital disease but also to its cosmetic enhancement. Diagnosing a vulval disease demand a careful examination of the private parts, and this needs a blend of social skill, scientific mind, clear-cut knowledge, and earned faith with the subject. All vulvar diseases are out of the scope of this chapter, and hence our discussion will be limited to pigmentary disorders of female external genitalia. 1 out of 10 women face pigmented lesions on their vulva though most of them are physiological and benign, yet knowledge about some treatable diseases is essential to avoid unnecessary cosmetic intervention and avoidance of disfigurement or severe disease upon delaying exact treatment [1]. Attention to vulval diseases are given only when its having diseases. Diagnosis of genital skin issues needs social skill, scientific mind, good knowledge. Recent interest in cosmetic enhancement of the area also demands skilful procedural dermatological intervention. Most of the diseases of vulva are treatable if detected at proper time. Lichen simplex et atrophicus (LSA) can lead to disfigurement and carcinoma if not treated early; and confusion with vitiligo is a rule in early disease. Hyperpigmentation on that region is mostly benign but melanoma to be rules out and need detail examination and or further investigation. A knowledge of vulval anatomy & physiology of different age is of utmost importance for accurate diagnosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rock B, Hood AF, Rock JA. Prospective study of vulvar nevi. J Am Acad Dermatol. 1990;22(1):104e6.
Friedrich E, Burch K, Bahr J. The vulvar clinic: an eight-year appraisal. Am J ObstetGynecol. 1979;135:1036e40.
Lynch PJ. Pigmented disorders. In: Edwards L, Lynch PJ, editors. Genital dermatology atlas. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2010. p. 170e85.
Ball SB, Wojnarowska F. Vulvar dermatoses: lichen sclerosus, lichen planus, and vulval dermatitis/lichen simplex chronicus. In Seminars in cutaneous medicine and surgery. 1998;17(3):182–8.
McKay M. Vulvodynia versus pruritus vulvae. Clin Obstet Gynecol. 1985;28(1):123–33.
Carlson JA, Lamb PM, Malfetano J, Ambros RA, Mihm MC. Clinicopathologic comparison of vulvar and extragenital lichen sclerosus: histologic variants, evolving lesions, and etiology of 141 cases. Mod Pathol. 1998;11(9):844–54.
Stewart KMA. Clinical care of vulvar pruritus, with emphasis on one common cause, lichen simplex chronicus. Dermatol Clin. 2010;28(4):669–80.
Thorstensen KA, Birenbaum DL. Recognition and management of vulvar dermatologic conditions: lichen sclerosus, lichen planus, and lichen simplex chronicus. J Midwifery Womens Health. 2012;57(3):260–75.
Moyal-Barracco M, Edwards L. Diagnosis and therapy of anogenital lichen planus. Dermatol Ther. 2004;17:38–46.
Ridley CM. Chronic erosive vulval disease. Clin Exp Dermatol. 1990;15:245–52.
Fischer G. Vulvar fixed drug eruption. J Reprod Med. 2007;52:81–6.
Arnold AW, Häusermann P, Bach S, Bircher AJ. Recurrent flexural exanthema (SDRIFE or baboon syndrome) after administration of two different iodinated radio contrast media. Dermatology. 2007;214(1):89–93.
Ozdemir S, Kepil F, Erkekol O, Aydin O, Celik GE, Misirligil Z. Fixed drug eruption due to meloxicam. J Investig Allergol Clin Immunol. 2011;21(5):419.
Wain EM, Neill S. Fixed drug eruption of the vulva secondary to fluconazole. Clinical and Experimental Dermatology: Viewpoints in dermatology. 2008;33(6):784–5.
Margesson LJ. Contact dermatitis of the vulva. Dermatol Ther. 2004;17:20–7.
Crone AM, et al. Aetiological factors in vulvar dermatitis. J Eur Acad Dermatol Venereol. 2000;14:181–6.
Brenan JA, et al. Evaluation of patch testing in patients with chronic vulvar symptoms. Australas J Dermatol. 1996;37:40–3. Margesson LJ. Contact dermatitis of the vulva. Dermatol Ther2004;17:20–7. https://doi.org/10.1111/j.1396-0296.2004.04003.x.
Haverhoek E, Reid C, Gordon L, et al. Prospective study of patch testing in patients with vulval pruritus. Australas J Dermatol. 2008;49:80–5. https://doi.org/10.1111/j.1440-0960.2008.00442.x.
Bhate K, Landeck L, Gonzalez E, Neumann K, Schalock PC. Genital contact dermatitis: a retrospective analysis. Dermatitis. 2010;21(6):317–20.
Edwards L. Pigmented vulvar lesions. Dermatol Ther. 2010;23(5):449–57.
Moyal-Barracco M, Wendling J. Vulvar dermatosis. Best Practice & Research Clinical Obstetrics &Gynaecology. 2014;28(7):946–58.
Venkatesan A. Pigmented lesions of the vulva. Dermatol Clin. 2010;28(4):795–805.
Grasinger CC, Wild RA, Parker IJ. Vulvar acanthosis nigricans: a marker for insulin resistance in hirsute women. Fertil Steril. 1993;59(3):583–6.
Puri N. A study of pathogenesis of acanthosis nigricans and its clinical implications. Indian J Dermatol. 2011;56(6):678.
Mikhail GR, FachnieD’Anne M, Drukker BH, Farah R, Allen HM. Generalized malignant acanthosis nigricans. Arch Dermatol. 1979;115(2):201–2.
Kellett HA, Collier A, Taylor R, Sawers JSA, Benton C, Doig A, Baird D, Clarke BF. Hyperandrogenism, insulin resistance, acanthosis nigricans, and systemic lupus erythematosis associated with insulin receptor antibodies. Metabolism. 1988;37(7):656–9.
Rock B. Pigmented lesions of the vulva. Dermatol Clin. 1992;10(2):361–70.
Alam M, Stiller M. Direct medical costs for surgical and medical treatment of condylomata acuminata. Arch Dermatol. 2001;137(3):337–41.
Rock B, Hood AF, Rock JA. Prospective study of vulvar nevi. J Am Acad Dermatol. 1990;22(1):104–6.
El Shabrawi-Caelen L, Soyer HP, Schaeppi H, Cerroni L, Schirren CG, Rudolph C, Kerl H. Genital lentigines and melanocytic nevi with superimposed lichen sclerosus: a diagnostic challenge. J Am Acad Dermatol. 2004;50(5):690–4.
Mannone F. Vincenzo De Giorgi, Antonio Cattaneo, Daniela Massi, Angelina De Magnis, and Paolo Carli. “Dermoscopic features of mucosal melanosis.”. Dermatol Surg. 2004;30(8):1118–23.
Barnhill RL, Albert LS, Shama SK, Goldenhersh MA, Rhodes AR, Sober AJ. Genital lentiginosis: a clinical and histopathologic study. J Am Acad Dermatol. 1990;22(3):453–60.
Nogita T, Mitsuhashi Y, Takeo C, Tsuboi R. Removal of facial and labial lentigines in dyschromatosis universalis hereditaria with a Q-switched alexandrite laser. J Am Acad Dermatol. 2011;65(2):e61–3.
Erkek E, SeldaHizel CS, Erkek AB, Tombakoglu M, Onder Bozdogan SU, Akarsu C. Clinical and histopathological findings in Bannayan-Riley-Ruvalcaba syndrome. J Am Acad Dermatol. 2005;53(4):639–43.
Lodish MB, Stratakis CA. The differential diagnosis of familial lentiginosis syndromes. Familial Cancer. 2011;10(3):481–90.
Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature. 2001;411(6835):355–65.
Murzaku EC, Penn LA, Hale CS, Pomeranz MK, Polsky D. Vulvar nevi, melanosis, and melanoma: an epidemiologic, clinical, and histopathologic review. J Am Acad Dermatol. 2014;71(6):1241–9.
Sturgeon SR, Brinton LA, Devesa SS, Kurman RJ. In situ and invasive vulvar cancer incidence trends. Am J Obstet Gynecol. 1992;166:1482–5.
Trone JC, Guy JB, Mery B, LangrandEscure J, Lahmar R, Moncharmont C, et al. Melanomas of the female genital tract: state of the art. Bull Cancer. 2014;101:102–6.
Rigel DS, Friedman RJ, Kopf AW, Polsky D. ABCDE—an evolving concept in the early detection of melanoma. Arch Dermatol. 2005;141(8):1032–4.
Chatterjee S. Debangshu Dey, Sugata Munshi, and SurajitGorai. “Extraction of features from cross correlation in space and frequency domains for classification of skin lesions.”. Biomedical Signal Processing and Control. 2019;53:101581.
Kara M. E. Colgecen, and Erdogan Nilsen Yildirim. “Vulvar basal cell carcinoma.”. Indian J Pathol Microbiol. 2012;55(4):583.
Rambhia K, Shah V, Singh R. Dermoscopy of pigmented basal cell carcinoma. Pigment International. 2018;5(2):123–4.
Deepadarshan K, Mallikarjun M, Abdu Noshin N. Pigmented basal cell carcinoma: a clinical variant, report of two cases. J Clin Diagn Res. 2013;7(12):3010.
Sarhan D, Mohammed GFA, Gomaa AHA, Eyada MMK. Female genital dialogues: female genital self-image, sexual dysfunction, and quality of life in patients with vitiligo with and without genital affection. J Sex Marital Ther. 2016;42(3):267–76.
Parsad D. Mucosal vitiligo. In: Vitiligo. Berlin, Heidelberg: Springer; 2010. p. 57–9.
Nair PA. Vulvar lichen sclerosus et atrophicus. Journal of mid-life health. 2017;8(2):55.
Ridley CM. Lichen sclerosus et atrophicus. Arch Dermatol. 1987;123(4):457–60.
Barker LP, Gross P. Lichen sclerosus et atrophicus of the female genitalia: a clinical study and diagnostic guide. Arch Dermatol. 1962;85(3):362–73.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Gorai, S., Lahiri, K. (2022). Hypo and Hyperpigmentary Disorders of Vulva. In: Jindal, P., Malhotra, N., Joshi, S. (eds) Aesthetic and Regenerative Gynecology. Springer, Singapore. https://doi.org/10.1007/978-981-16-1743-0_19
Download citation
DOI: https://doi.org/10.1007/978-981-16-1743-0_19
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-1742-3
Online ISBN: 978-981-16-1743-0
eBook Packages: MedicineMedicine (R0)